source
- Treasury's Proposed China Investment Rule Sparks Debate Over Licensing ExemptionsThe U.S. Treasury Department recently proposed a rule that would limit American investment in Chinese biotechnology companies, prompting immediate discussion among industry stakeholders. Commentat…
- HHS issues interim policy allowing compounding of six unapproved peptides under set conditionsHHS announced an interim policy that will not take enforcement action against state-licensed pharmacies, federal facilities, or licensed physicians that compound six unapproved peptide bulk drug su…